Prostate cancer is a major concern for men's health, being one of the main causes of death in men. Therefore, any advance in its early detection is relevant news for almost half of the world's population.
Recently, the development of a promising new process for detecting prostate cancer early and easily has been announced. This method uses ultrasound technology, widely available and relatively inexpensive in most hospitals.
The procedure consists of intravenously injecting a solution containing millions of microbubbles. These microbubbles travel through the bloodstream to the prostate, where they are visualized by ultrasound. In the presence of cancer, a color change occurs in the blood flow observable in the ultrasound, as can be seen in the image below.
Clinical tests of this new process have shown a 94% accuracy, a very encouraging result. Although it is still in the testing phase and is expected to take about five years to become available in hospitals, it represents a significant advance in the fight against prostate cancer.
Early detection is crucial for the successful treatment of prostate cancer. An early diagnosis considerably increases the chances of overcoming the disease. Currently, men over 50 are recommended to have annual blood tests to measure prostate-specific antigen (PSA). If the PSA level exceeds 4 ng/ml, a more thorough urological evaluation is recommended.
This new detection method, based on microbubbles and ultrasound, offers a potentially simpler and more accessible alternative for early diagnosis. Its future implementation in hospitals could make a significant difference to the quality of life of millions of men around the world.
We hope that its development will continue successfully and will soon be available to everyone.
EN 
ES